Venture Investments on July 23, 2026: CuspAI $450 Million, Neo $100 Million and Strategic Capital Growth

Venture Market Update - 23 July 2026: CuspAI Secures $450 Million in Round at $2.6 Billion Valuation, Neo Emerges from Stealth with $100 Million, Transactions Involving Natural, Empirical Security, Infinity, Brenus Pharma, and Plazza, Analysis of Capital Shift towards the Control Layer of AI for Venture Investors and Funds

Key Takeaway: The venture market has shifted from paying for access to models to investing in control over the bottlenecks surrounding them. The $450 million round for CuspAI at a $2.6 billion valuation, Neo's stealth exit with $100 million, and a wave of strategic investments from corporations and private equity are shaping a new logic in capital allocation. We explore what this means for venture funds and limited partners (LPs).

Venture investments as of mid-July 2026 are not broadly distributed across the startup landscape. Capital is clearly leaning towards infrastructure, security, and software that resides in the AI control layer rather than the presentation layer. The largest cheque of the cycle has gone to AI material development, while other notable rounds are clustered around cybersecurity, inference software, payment rails for AI agents, and automation of regulated workflows.

This combination is significant for investment committees. It shows that funds still want exposure to AI, but increasingly prefer businesses that shape the economics of computation, control over data, or critical corporate processes, rather than yet another thin layer on top of a frontier model.

Deal of the Day: CuspAI Raises $450 Million at a $2.6 Billion Valuation

The Series B round for UK-based CuspAI was a defining transaction of the week, as it points to where deep-pocketed investors see the next defensive moat in AI—not only in the models but also in the physical systems that these models help design.

• Round Size: $450 million, Series B, $2.6 billion valuation.
• Investors: Led by Kleiner Perkins and NEA, with participation from Bezos Expeditions, the UK government, AMD Ventures, Lux Capital, Glade Brook Capital Partners, and Invest-NL.
• Total Funding: Over $650 million raised in just two years since launch.
• Headquarters: Cambridge, UK.

The company employs AI to discover new materials, focusing on semiconductors, batteries, clean energy, and advanced manufacturing. Investors are compelled by the fact that these materials sit upstream of several constrained markets. Should AI effectively reduce semiconductor production's dependency on rare metals, shorten R&D cycles, or enhance energy materials, the returns will not just be limited to software multipliers—they will cascade into manufacturing economics, supply chain resilience, and geopolitical competitiveness.

For founders, the lesson here is stern: such capital-intensive deep tech ventures will only be funded when the project is tied to strategic industrial demand, rather than an abstract scientific promise.

Cybersecurity as a Magnet for Venture Capital

The second major cluster of deals is in cybersecurity, and this is no coincidence. AI is not just creating new categories of software; it is rewriting the risk model for existing ones.

Neo: $100 Million Exit from Stealth

Boston-based Neo has secured $100 million in a combined seed and Series A round led by Andreessen Horowitz, Bessemer Venture Partners, Craft Ventures, and Merlin Ventures. The company was founded by former SentinelOne executives Nick Warner and Shlomi Salem along with technologist Eran Shirazi. The thesis is straightforward: traditional corporate security tools are poorly suited to the world of AI applications and agent systems. The platform enables security teams to see, verify, and control AI software before data access or automated actions create new operational risks. The technology is currently undergoing pilots in finance, energy, and transport.

Empirical Security: $25 Million to Predict Exploited Threats

The Chicago-based firm raised a Series A led by Brightmind Partners with participation from HPA and Costanoa Ventures, bringing total funding to $37 million. The positioning is noteworthy: instead of broad rhetoric about "AI security," the company focuses on threat prediction through the monitoring of exploited vulnerabilities. Budgets are opening up faster for software that helps prioritise specific vulnerabilities than for platforms that merely promise "more intelligence."

Second Order AI Stack: Software Making Hardware Useful

Of particular interest to venture investors is the seed round for Infinity, which raised $15 million at a post-money valuation of $100 million. The company is building a software layer that makes any AI chip ready for inference.

The investment thesis here is simple: new chips matter little if developers cannot quickly deploy on them. Nvidia’s dominance in AI is largely due to its software and the maturity of its ecosystem, not just hardware performance. Infinity effectively sells time-to-utility: if new silicon makers can become inference-ready in days rather than months or years, they gain a chance to compete for manufacturing demand.

A deeper signal is that venture capital is seriously considering the "second order AI stack." The market has already poured significant resources into model developers and chip companies. The next funds are flowing to transactors, adapters, and orchestration layers that make this infrastructure usable.

Agent Commerce: Payment Rails for AI

The startup Natural closed a Series A for $30 million led by Kirsten Green of Forerunner, bringing total funding to $40 million. The company addresses a challenge that will grow with each viable agent scenario: how software executes financial actions on behalf of a user or company without chaos in access rights, payment friction, and compliance issues.

The logic of investors is clear:

1. Agent commerce is easy to demonstrate and difficult to bring to industrial-scale.
2. Once software begins buying software, paying suppliers, and handling transactional processes, the product becomes the rails themselves.
3. The owner of this layer captures volume, compliance, and embedded distribution far beyond the capabilities of a thin application.

This gives the company a more resilient position than many applied AI startups, whose differentiation blurs as foundational models improve. For founders, the distinction is critical: AI that saves a click will struggle to attract attention; AI that safely moves a dollar draws strategic capital.

Return of Strategic Capital: PE, Corporations, and Distribution Channels

One of the most notable features of the current market is the significant portion of strategically necessary funding that has not come from traditional venture funds, but rather from private equity, corporate, and ecosystem partners.

• Quorum (Washington) secured undisclosed strategic investment from Enlightenment Capital. The AI-based platform for government affairs serves over 2,000 organisations, including more than half of the Fortune 100 companies. The capital will be directed towards executing the product roadmap and expanding agent AI capabilities.
• Wagmo (New York) attracted strategic investment from Curql to bring modern veterinary med insurance into the channel of credit unions—an example of distribution-oriented capital.
• HALO X-ray Technologies (Nottingham, UK) closed a multi-million round led by Agilent with participation from the UK Innovation Science Seed Fund and Midland Engine Investment Fund to finalize regulatory approval of diffraction X-ray technology in screening systems.

When buyers, channels, or industry experts can fund part of the next chapter of growth, founders become less reliant on purely financial sponsors. In a tighter capital market, this is an advantage.

Biotech and Healthcare: Funding Based on Milestones, Not Narratives

Lyon-based Brenus Pharma added €11 million to its Series A round, raising total funding since inception to €38 million. The expansion is tied to achieving clinical, regulatory, and business development milestones around STC-1010—a leading clinical immunotherapeutic programme for stomach and colorectal cancer. The company also noted the arrival of new investors from Europe and the Asia-Pacific region.

Such expansions are important as indicators of risk underwriting. Instead of forcing every company into a new narrative reboot, investors are willing to add capital when the team has sufficiently de-risked the science. This is often healthier than a completely new round at an inflated valuation, as it directly ties capital to progress.

In India, Plazza (Bengaluru) raised $15 million in a Series A led by Accel, Elevation Capital, and Nexus Venture Partners to expand its pharmacy network and instant medicine delivery. This is a bet on logistics and trust in a category where reliability matters more than brand storytelling: availability, order fulfilment rate, inventory routing, and locality coverage form a true defensive moat.

Geography of Capital: A Market Without a Single Template

The current venture landscape is geographically mixed but uneven:

1. USA dominates early-stage software and cybersecurity—Neo, Empirical Security, Infinity.
2. UK has secured the largest cheque of the cycle through CuspAI and demonstrated strength in deep tech with government capital involvement.
3. France has emerged through biotech and clinically validated assets.
4. India has entered the conversation through operations-heavy commerce in healthcare rather than frontier AI.

Global venture does not converge into a single template. Different regions attract capital where they already have talent density, regulatory competence, or operational advantages.

Cycle Risks: Where Venture Funds Might Overpay

The discipline of the current market does not abolish structural threats to portfolios:

• Risk of Commoditisation. AI applications built on widely available models may grow, but sustainable money is shifting beneath or around the model layer.
• Uneven Disclosure. A significant portion of strategically interesting transactions occurs without disclosure of amounts, complicating benchmark evaluations.
• Capital Intensity of Deep Tech. Computing, lab processes, and industrial partnerships are expensive, meaning continuous dilution of early investors' stakes.
• Concentration in Narrow Categories. When the market pays primarily for infrastructure, security, and science, correlation of risks within the portfolio increases.
• Dependence on Regulatory Milestones. In biotech and physical security, approval timelines remain a chief source of uncertainty.

Conclusions for Venture Investors and Funds

The current deal flow reflects a market attempting to assess not novelty but where AI creates sustainable scarcity. In some cases, it is a scarce scientific competence, as seen with CuspAI. In others, it is scarce trust, as with cybersecurity and public policy software. In yet others, it is scarce operational reliability, as in medicine delivery.

Practical takeaways for investment committees include:

1. Finance Bottlenecks, Not Slogans. If a startup addresses infrastructure cost, security status, compliance processes, or high-frequency order fulfilment, significant rounds are still being underwritten.
2. Seek Accumulating Defensibility. Scientific intellectual property and industrial partnerships, founder reputation, ecosystem leverage, progress on scientific milestones—the common denominator is not technology but the ability to make a replacement painful.
3. Consider the Type of Investor as a Cost Factor. Sometimes, the most valuable investor is not the one paying the highest price but the one opening the most cost-effective and secure route to customers.
4. Ask What the Next Dollar Changes. Expansions, strategic investments, and concentrated early rounds are displacing broad syndication based on hype—both sides of the market are becoming more disciplined.
5. Bet on Layers around Autonomy. Payments, security, chips, science, and workflow infrastructure benefit from AI while remaining difficult to commoditise. It is likely that premium multipliers will concentrate there.

The next phase of startup financing appears less like a race to attach AI to everything and more like a competition to control the systems that make AI safe, deployable, and economically valuable. The companies winning capital now are not just promising automation—they are defining who controls the bottlenecks around it.